SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is surging as strong Azure revenue growth and accelerating AI demand successfully quelled investor anxieties regarding high capital expenditures. Market participants are actively discussing the stock's role as a major catalyst for tech sector sentiment, with many highlighting the massive short interest that is now fueling potential squeeze dynamics.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is seeing intense volatility as investors weigh conflicting market signals, including a sell-off triggered by institutional liquidations and broader sector rotation against reports of robust AI infrastructure demand from major hyperscalers. The community remains sharply divided, with many traders debating whether recent price drops represent a prime buying opportunity ahead of upcoming earnings or a fundamental shift in the AI infrastructure narrative.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing significant volatility and a short squeeze as investors weigh blowout quarterly earnings and raised full-year guidance against broader market liquidations. Community discussions are centered on the company's role in powering AI data centers, with many traders debating whether the stock's massive single-day swings reflect genuine structural demand or purely mechanical trading dynamics.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

SOXS is experiencing heightened volatility and intense social media discussion as retail investors debate the impact of semiconductor supply chain vulnerabilities and geopolitical tensions on chip stocks. Many traders are actively navigating the ETF's rapid price swings, with intense community focus on timing exits and entries amidst concerns over the instrument's structural decay and history of reverse splits.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Investors are closely monitoring the iShares 20+ Year Treasury Bond ETF as Treasury yields climb toward multi-year highs, fueling speculation about the Federal Reserve's next policy moves and the impact of persistent geopolitical tensions. The community remains deeply divided, with some betting on a flight-to-safety trade driven by potential equity market volatility, while others caution that sustained inflation and rising energy costs continue to exert downward pressure on long-duration bond prices.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The QQQ is experiencing intense volatility as investors weigh robust earnings from major cloud providers against macroeconomic concerns, including shifting interest rate expectations and regional geopolitical tensions. The market is currently characterized by a sharp tug-of-war between aggressive technical buying and skepticism from retail traders who remain wary of broader economic stability.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is currently seeing intense community debate as investors weigh strong operational fundamentals, such as record network volume and massive ABS issuance, against persistent stock price volatility and downward pressure. Many shareholders are actively discussing the stock's undervaluation relative to its growth, while others express frustration over institutional manipulation and the lack of price momentum despite positive news.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit shares are seeing extreme volatility and intense community debate as investors grapple with a sharp selloff driven by sector rotation away from software and toward AI-focused semiconductor stocks. While traders are actively debating whether the current price represents a generational value opportunity or a long-term structural decline due to AI disruption, many are focused on the company's strong cash flow, buyback authorizations, and its dominant position in tax and accounting software.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is seeing heightened investor attention as strong revenue growth and Rezdiffra patient adoption face scrutiny over significant operational spending. While the market reacts to these earnings pressures, the community remains divided between long-term bullish sentiment regarding the drug's blockbuster potential and persistent speculation surrounding a potential acquisition by larger pharmaceutical players.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is attracting heavy investor focus ahead of its upcoming earnings report, with the community actively debating whether aggressive AI infrastructure investments and AWS growth will justify recent capital expenditure levels. Traders are also monitoring news regarding Amazon's expansion into satellite connectivity and robotaxis as potential long-term catalysts amidst broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

MannKind stock rose after the FDA approved Furoscix ReadyFlow, as the company also announced a $50 million private placement financing.read more...

MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost  

Equity

FDA approved MannKind’s Furoscix ReadyFlow on Friday.

MNKD Stock Rises Premarket As FDA Verdict Nears – Retail Optimism Builds 

The FDA is expected to announce its decision on MannKind’s sNDA on July 26, 2026.


What This MannKind Filing Reveals About Three Years of Underperformance

Key PointsThis MannKind insider filing details the disposition of 46,795 shares...

What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk

Key PointsThe transactions involved 76,880 shares with a total value of about $313,000, based on a weighted average execution price of $4.07 per share...

What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million

Key PointsDavid Thomson disposed of 123,000 shares at $4.08 per share, representing a total transaction value of about $500,000...

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

Key PointsThis filing reported an insider's total disposition of 65,808 shares for an estimated value of $269,000 based on the July 15, 2026 market close...

Is MannKind a Stock to Sell After Its CEO Let Go of 363,200 Shares?

Key PointsThe disposition involved ~363,000 shares valued at ~$1.5 million as of the July 15, 2026 transaction date...

Jim Cramer Says He Blessed MannKind as a Speculation Only

Jim Cramer Says He Blessed MannKind as a Speculation Only...

S&P 500 Jumps For Ninth Week, Longest Since 2023 With DELL Leading Nasdaq To Record Highs, While Positive US-Iran Ceasefire Bets Aid Dow —  UMG, COIN, MNKD, ASTC, ASTS In Focus

President Donald Trump said he was ready to make a “final determination” on a preliminary agreement to extend the ceasefire.

$MNKD Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.05 down -225.00% YoY
• Reported revenue of $90.17M up 15.08% YoY
• MannKind believes its resources will be sufficient to fund operations for at least the next 12 months, supported by cash, investments, and revenue from Afrezza, Furoscix, V-Go, and Tyvaso DPI royalties.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MNKDMannkind Corp

Fundamentals

Latest MNKD News